Deka STOXX Europe 50® UCITS ETF | EL4YRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -1.0 | 18.1 | 4.1 | 11.9 | 8.1 | |
+/-Cat | -5.3 | 2.7 | 12.4 | 0.4 | 3.7 | |
+/-B’mrk | -3.5 | 0.4 | 8.7 | -1.3 | 2.8 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 08/05/2024 | EUR 45.52 | |
Day Change | 0.82% | |
Bid (07/05/2024) | EUR 44.74 | |
Offer (07/05/2024) | EUR 46.10 | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 2415 | |
Exchange | DEUTSCHER KASSENVEREIN AG GRUPPE DEUTSCHE BOERSE | |
ISIN | DE000ETFL250 | |
Fund Size (Mil) 07/05/2024 | EUR 85.88 | |
Share Class Size (Mil) 07/05/2024 | EUR 85.88 | |
Ongoing Charge 12/04/2024 | 0.20% |
Investment Objective: Deka STOXX Europe 50® UCITS ETF | EL4Y |
The Deka STOXX Europe 50® UCITS ETF is a UCITS IV compliant public fund that tracks the performance of the STOXX Europe 50® (price index). The index comprises 50 European Blue Chips from up to 18 European Countries. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 08/04/2009 | ||
Inception Date 08/04/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 50 PR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Deka STOXX Europe 50® UCITS ETF | EL4Y | 07/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 7.13 |
ASML Holding NV | Technology | 6.34 |
Nestle SA | Consumer Defensive | 4.67 |
Shell PLC | Energy | 4.07 |
AstraZeneca PLC | Healthcare | 4.06 |
Increase Decrease New since last portfolio | ||
Deka STOXX Europe 50® UCITS ETF | EL4Y |